Follow-The-Filings

MDGL · Madrigal Pharmaceuticals Inc.

Q4 2023 13F holders

← latest ownership dossier

Ticker
MDGL
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares